Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease
NCT06129409
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Cardiovascular Diseases
Interventions
DRUG:
NT-0796
Sponsor
NodThera Limited